Home › Scleroderma › Connecticut
Scleroderma clinical trials in Connecticut
4 studies for Scleroderma are looking for participants at sites in Connecticut.
Cities in Connecticut
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Smilow Cancer Center/Yale-New Haven Hospital, New Haven
- Yale University, New Haven
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
- Yale University, New Haven
RecruitingPhase 2/3
Ages 18 to 75 · All sexes · Updated Aug 17, 2026 · NCT06328777Quantification of Calcinosis Cutis Disease Burden Using Computed Tomography Images
- Yale Scleroderma Program, New Haven
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 17, 2026 · NCT07228429Rheumatology Patient Registry and Biorepository
- Yale New Haven Hospital, New Haven
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 99 · All sexes · Updated Feb 13, 2026 · NCT04402086From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.